Main Session
Sep
28
PQA 02 - Lung Cancer/Thoracic Malignancies, Patient Reported Outcomes/QoL/Survivorship, Pediatric Cancer
2521 - The Impact of Effective Dose to Immune Cells and Platelet-to-Lymphocyte Ratio on Lymphopenia and Prognosis in Patients with Unresectable Locally Advanced Non-Small Cell Lung Cancer
Presenter(s)
Haoting Yang, MD - Shandong Provincial Key Laboratory of Precision Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong